ABIVAX Société Anonyme (ABVX.PA) • EURONEXT
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold ABVX.PA in your mock portfolio yet.
ABIVAX Société Anonyme is currently loss-making, as indicated by its negative EPS and negative P/E ratio. This suggests the company has yet to reach sustainable profitability and is likely still in an investment or development-heavy phase. Without evidence of improving earnings trends, the financial profile leans clearly toward higher risk.
The stock has declined 25.5% over the last month and trades below its 200-day moving average, signaling a weak technical setup. The current price of €85.80 versus a 200-day moving average of €96.26 suggests a medium-term downtrend. Unless there is a strong catalyst, the technical picture points to continued pressure or at best consolidation.
Alternative data for ABIVAX Société Anonyme is mixed but not strongly positive. Web traffic of roughly 25,835 monthly visitors and modest social media followings suggest limited but non-negligible investor and stakeholder interest. Flat hiring (0 job openings) points to a stable but non-expansionary posture, which neither strongly supports nor undermines the current equity story.
Overall, ABIVAX Société Anonyme’s profile appears bearish at this time. The combination of ongoing losses, a negative P/E, and a sharp recent price decline below the 200-day moving average outweighs the relatively neutral alternative data signals. Without clear evidence of improving fundamentals or strong growth catalysts, the risk-reward skews negatively in the near to medium term.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started